Quest Diagnostics Incorporated (NYSE:DGX) to go ex-dividend.
On 8/18/2017 Quest Diagnostics Incorporated ( NYSE:DGX ) announced that it will be issuing a quarterly dividend in the amount of $0.45 down from $0.45 making the yield 1.72%.


Quest Diagnostics Incorporated (NYSE:DGX) Ex- dividend date

Quest Diagnostics Incorporated (NYSE:DGX) is set to go ex-dividend on 10/2/2017 and will be payable on 10/18/2017


Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)
The next payable dividend for Quest Diagnostics Incorporated is scheduled for 10/18/2017. There is an annual dividend of $$1.80 with a yield of 1.72% The company’s dividend has increased by 9.60% on a 3 Year Average The payout ration for the trailing 12 months of earnings is 36.29% , 31.63% based on this years estimates and 30.20% based on next years projected estimates.

Recent Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)

• On 2/26/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30.
• On 5/21/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30.
• On 8/20/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30.
• On 12/6/2013 Quest Diagnostics Incorporated announced a quarterly dividend of $0.30.
• On 1/30/2014 Quest Diagnostics Incorporated announced a quarterly dividend of $0.33.
• On 5/21/2014 Quest Diagnostics Incorporated announced a quarterly dividend of $0.33.

Recent Insider Trading for Quest Diagnostics Incorporated (NYSE:DGX)

• On 8/4/2017 Jeffrey M Leiden, Director, sold 296 with an average share price of $106.66 per share and the total transaction amounting to $31,571.36.
• On 7/27/2017 Jeffrey M Leiden, Director, sold 1,304 with an average share price of $108.73 per share and the total transaction amounting to $141,783.92.
• On 6/19/2017 Catherine T Doherty, SVP, sold 59,762 with an average share price of $107.55 per share and the total transaction amounting to $6,427,403.10.
• On 4/24/2017 Jenne K Britell, Director, sold 6,111 with an average share price of $104.03 per share and the total transaction amounting to $635,727.33.
• On 4/20/2017 Michael E Prevoznik, SVP, sold 29,513 with an average share price of $100.00 per share and the total transaction amounting to $2,951,300.00.
• On 3/16/2017 Michael E Prevoznik, SVP, sold 13,987 with an average share price of $100.00 per share and the total transaction amounting to $1,398,700.00.

Recent Analyst Rating for Quest Diagnostics Incorporated (NYSE:DGX)

• On 8/10/2017 Morgan Stanley, Boost Price Target, to Underweight with a price target of $87.00 to $92.00
• On 7/25/2017 Bank of America Corporation, Upgrade, fromNeutral to Buy to Neutral with a price target of $111.00 to $118.00
• On 7/25/2017 Piper Jaffray Companies, Boost Price Target, to Neutral with a price target of $107.00
• On 7/19/2017 Barclays PLC, Reiterated Rating, to Hold with a price target of $110.00
• On 7/13/2017 Credit Suisse Group, Reiterated Rating, to Neutral with a price target of $83.00 to $110.00
• On 6/28/2017 Evercore ISI, Reiterated Rating, to In-Line with a price target of $104.50

Recent Trading for Quest Diagnostics Incorporated (NYSE:DGX)
Shares of Quest Diagnostics Incorporated closed the previous trading session at 104.87 down -0.50 -0.47% with 778,139 shares trading hands.